On (b)(6) 2023 leica biosystems received the confirmation, that the customer experienced suboptimal tissue processing on their asp6025, tissue processor.As a result the tissue was undiagnosable, and a rebiopsy for 9 patients was recommended.
|
The investigation revealed the following: the instrument logs were analyzed by the lbs senior quality engineer, and no instrument error was detected during the processing steps that could conceivably be linked to the damaged tissue.The incident was presumably user related due to an application issue (thresholds set up).Test runs have been conducted successfully after the changing all reagents and paraffin.According to the lbs senior quality engineer, the purity of the xylene (s8) and paraffin(i) used may have been insufficient to meet processing requirements, which may have caused the tissues to be under processed.Also, the ethanol concentrations in s1, s2, s3 and s4 significantly exceeded the ifu recommendation.A recommendation was made to the customer to optimize the thresholds for the reagents and the paraffin.
|